Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note

AAPS PharmSciTech

Volumn 7, Issue 3, 2006, Pages

  Merchant, Hamid A ^a   Shoaib, Harris M ^a   Tazeen, Jaweria ^a   Yousuf, Rabia I ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Cefpo SR; Cefpodoxime proxetil; Hydrophilic matrix tablets; Hydroxypropyl methyl cellulose (HPMC); In vitro sustained drug release; Once daily tablet

Indexed keywords

CEFPODOXIME PROXETIL; HYDROXYPROPYLMETHYLCELLULOSE; CEFPODOXIME; CEFTIZOXIME; DRUG DERIVATIVE; METHYLCELLULOSE;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DIFFUSION; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG SOLUBILITY; HYDROPHILICITY; IN VITRO STUDY; PATIENT COMPLIANCE; SUSTAINED DRUG RELEASE; TABLET FORMULATION; CHEMISTRY; DELAYED RELEASE FORMULATION; ENTERIC COATED TABLET; EVALUATION; METHODOLOGY;

CEFTIZOXIME; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; METHYLCELLULOSE; TABLETS, ENTERIC-COATED;

EID: 33749666655     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt070378     Document Type: Article

References (24)

1. Alderman DA. A review of cellulose ethers in hydrophillic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr. 1984;5:1-9.
2. Dow Chemical Company. Using methocel cellulose ethers for controlled release of drugs in hydrophillic matrix systems. Available at: http:// www.dow.com/PublishedLiterature/dh_01e7/ 09002fl3801e718c.pdf?filepath=methocel/pdfs/noreg/ 198-02075.pdf&fromPage=GetDoc. Accessed August 24 2006
3. Dollery C. Therapeutic Drugs. Edinburgh, Scotland: Churchill Livingstone; 1999:C113-C117.
4. Todd WM. Cefpodoxime proxetil: a comprehensive review. Int J Antimicrob Agents. 1994;4:37-62.
5. Sader HS, Jones RN, Washington JA, et al. in vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis. 1993;17:143-150.
6. Orelox. Electronic medicines compendium, Aventis Pharma Ltd. Available at: http://emc.medicines.org.uk/emc/assets/c/html/displaydoc. asp?documentid=8940. Accessed: January 8, 2005.
7. 2 receptor antagonist. Antimicrob Agents Chemother. 1992;36: 796-800.
8. Wai-Yip Lee T, Robinson RJ. Controlled drug delivery systems. In: Gennaro AR, ed. Remington: The Science and Practice of Pharmacy. 20th ed. Philadelphia, PA: University of Sciences in Philadelphia; 2000:903-929.
9. Vantin. Pharmacia & Upjohn Company, Pharmacia Corporation. Available at: http://www.pfizer.com/download/uspi_vantin.pdf. Accessed: August 24, 2006.
10. Martindale. The Extra Pharmacopoeia. 31st ed. London, UK: Royal Pharmaceutical Society; 1996:193.
11. VIVAPHARM, cellulose-based polymer for film-coating and sustained release application. Available at: http://www.jrspharma.de. Accessed: January 8, 2005.
12. British Pharmacopoeia (B.P.). London, UK: Stationary Office London;2004.
13. United States Pharmacopeia-27. Rockville, MD: US Pharmacopeial Convention; 2004:377-379. Also pp778-780.
14. Qiu Y, Garren J, Samara E, et al. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in-vitro drug release method. J Pharm Sci. 2003;92:2317-2325.
15. Hadjiioannou TP, Christian GD, Koupparis MA. Quantitative Calculations in Pharmaceutical Practice and Research. New York, NY: VCH Publishers Inc; 1993:345-348
16. Bourne DW. Pharmacokinetics. In: Banker GS, Rhodes CT, eds. Modern Pharmaceutics. 4th ed. New York, NY: Marcel Dekker Inc; 2002:67-92.
17. Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145-1149.
18. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation I-theoretical consideration Ind Eng Chem 1931;23:923-931.
19. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25-35.
20. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139-157.
21. Saravanan M, Nataraj KS, Ganesh KS. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in-vitro release kinetics. Chem Pharm Bull (Tokyo). 2003;51:978-983.
22. Sood A, Panchagnula R. Drug release evaluation of diltiazem CR preparations. Int J Pharm. 1998; 175:95-107.
23. Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech. 2003;4:E61.
24. Fassihi RA, Ritschel WA. Multiple layer, direct compression controlled release system: in vitro and in vivo evaluation. J Pharm Sci. 1993;82:750-754.